Advisory Committee on Immunization Practices (ACIP) recommends a preference for using the nasal spray flu vaccine - Media Statement
Today, the Advisory Committee on Immunization Practices (ACIP) voted to recommend a preference for using the nasal spray flu vaccine (i.e., LAIV) instead of the flu shot (i.e., IIV) in healthy children 2-8 years of age when it is immediately available. ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC).
Today, the Advisory Committee on Immunization Practices (ACIP) voted to recommend a preference for using the nasal spray flu vaccine (i.e., LAIV) instead of the flu shot (i.e., IIV) in healthy children 2-8 years of age when it is immediately available. ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC).
This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.
Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.
Key Points
- Published by CDC.
- Categorized as Public Intelligence.
- Source handling: Verified Source.
- Rights posture: Public Domain.
- Follow the source article for the complete original report.